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ABSTRACT 
Valerie B. Idada-Parker: Using the Dual Diagnosis Capability of Addiction Treatment (DDCAT) 
Index to Improve Outcomes: An Evaluation of a Community-Based Behavioral Health Program 
(Under the direction of Dr. Cheryl Giscombe) 
  
 Agencies that provide services to individuals with coexisting mental health and substance 
abuse disorders (dual diagnosis) require guidance to understand their capability for 
comprehensively implementing integrated care to achieve optimal treatment outcomes.  The 
Dual Diagnosis Capability of Addiction Treatment (DDCAT) index was created by researchers 
with funding from SAMHSA to address this need.  The project was completed in a community-
based outpatient behavioral center.  It aimed to use the DDCAT index to evaluate a community-
based agency that provides substance abuse and mental health services to determine its capability 
of providing integrated care to the clients who are dually-diagnosed.  The project identified areas 
where the agency was well equipped to serve these clients, and determined where programmatic 
improvement was needed. Methods used for collecting data included observation, interviews and 
review of documents.  
 The investigator found that clinical process: treatment and continuity of care were the 
DDCAT domains that required the most improvement for endorsement for dual diagnosis 
capability, while staff training and program structure was the lowest priority.  Overall the staff 
acknowledged the usefulness of the evaluation.  The staff was confident that they could follow 
the DDCAT index recommendations and improve their scores. The study concluded that the  
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DDCAT index is a valuable tool to use to guide agencies to understand their capability for 
integrated care to achieve optimal treatment outcomes.   Mental health and addiction treatment 
programs can enhance dual diagnosis capable services by implementing recommendations using 
the DDCAT index. 
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CHAPTER 1: INTRODUCTION 
The Substance Abuse and Mental Health Services Administration (SAMSHA) has 
emphasized the importance of integrated care for individuals who suffer from dual diagnosis, 
which is the co-existence of mental health and substance abuse conditions.  It is critical to 
understand the relative strengths and weaknesses of programs or agencies treating dually 
diagnosed individuals in order to guide efforts to improve services.   Agencies that provide 
services to these individuals require guidance to understand their capability for comprehensively 
implementing integrated care to achieve optimal treatment outcomes.  The Dual Diagnosis 
Capability of Addiction Treatment (DDCAT) index was created by researchers with funding 
from SAMHSA to address this need.  Dual diagnosis programs that follow the guidelines of 
SAMSHA and offer integrated services are more likely to produce desired treatment outcomes 
such as: reduced hospitalization, medication compliance, lower relapse rates and control of 
psychiatric symptoms (Torrey, et al.  2002).   
The current project aimed to use the DDCAT to evaluate a community-based behavioral 
health agency (CBHA), CAARE, Inc., that provides substance abuse and mental health services 
to determine its capability of providing integrated care to the clients who are dually-diagnosed.   
The project identified areas where the agency is well equipped to serve these clients, and 
determined where programmatic improvement is needed. Written and oral feedback was 
provided to the agency staff to facilitate the provision of fully integrated services.    
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Background and Significance 
Dual diagnosis was first identified in the 1980s, and it is currently defined as co-
occurring substance related and mental health disorders (SAMHSA, 2006).    The existence of 
both disorders within individuals often results in poor treatment response and increased 
morbidity, particularly when either the mental illness or the substance abuse disorder goes 
untreated (SAMSHA, 2002).   
Figure 1 illustrates the definition of dual diagnosis, which occurs when a substance 
related disorder and mental disorder co-exist.   
 
   
Reprinted from SAMSHA.gov, 2014 
Figure 1: Overlap of Mood and Addictive Disorders 
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Substance dependence and substance abuse are defined according to criteria listed in the 
Diagnostic and Statistical Manual of Mental Disorders IV-TR (DSM-IV-TR) as meeting criteria 
for illicit drug or alcohol dependence or abuse.  The criterion for each disorder is listed below.    
DSM-IV-TR Criteria for Substance Dependence 
A maladaptive pattern of substance use, leading to clinically significant impairment or distress, 
as manifested by three (or more) of the following, occurring at any time in the same 12-month 
period: 
1. tolerance, as defined by either of the following: 
a. a need for markedly increased amounts of the substance to achieve intoxication or 
desired effect 
b. markedly diminished effect with continued use of the same amount of the substance  
2. withdrawal, as manifested by either of the following: 
a. the characteristic withdrawal syndrome for the substance  
b. the same (or a closely related) substance is taken to relieve or avoid withdrawal 
symptoms  
3. the substance is often taken in larger amounts or over a longer period than was intended  
4. there is a persistent desire or [there are] unsuccessful efforts to cut down or control 
substance use  
5. a great deal of time is spent in activities necessary to obtain the substance (e.g., visiting 
multiple doctors or driving long distances), use the substance (e.g., chain smoking), or 
recover from its effects  
6. important social, occupational, or recreational activities are given up or reduced because 
of substance use  
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7. the substance use is continued despite knowledge of having a persistent or recurrent 
physical or psychological problem that is likely to have been caused or exacerbated by 
the substance (e.g., current cocaine use despite recognition of cocaine-induced 
depression, or continued drinking despite recognition that an ulcer was made worse by 
alcohol consumption). 
DSM-IV-TR Criteria for Substance Abuse 
A. A maladaptive pattern of substance use leading to clinically significant impairment or 
distress, as manifested by one (or more) of the following, occurring within a 12-month period: 
1. recurrent substance use resulting in a failure to fulfill major role obligations at work, 
school, or home (e.g., repeated absences or poor work performance related to substance 
use; substance-related absences, suspensions, or expulsions from school; neglect of 
children or household)  
2. recurrent substance use in situations in which it is physically hazardous (e.g., driving an 
automobile or operating a machine when impaired by substance use)  
3. recurrent substance-related legal problems (e.g., arrests for substance-related disorderly 
conduct)  
4. continued substance use despite having persistent or recurrent social or interpersonal 
problems caused or exacerbated by the effects of the substance (e.g., arguments with 
spouse about consequences of intoxication, physical fights) 
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B. The symptoms have never met the criteria for substance dependence for this class of 
substance1.    
In America over 24 million individuals have reported severe psychological disorders and 
21.3 percent of this population have active substance abuse/dependence disorders (NSDUH, 
2006).  The National Survey on Drug Use and Health estimated 2.7 million adults over the age of 
18  reported that they had a major depressive episode and alcohol use disorder in 2006, with 40.7 
percent not receiving treatment for either disorder (NSDUH, 2007).  In figure 2 below SAMHSA 
reported that in 2014, 9. 2 million people in the USA had substance use disorder (SUD) and 
mental Illness, 11.2 had substance abuse without a mental illness diagnosis, while 36.7 million 
individuals had mental illness without substance abuse diagnosis (SAMHSA.gov, 2014) 
Figure 2. Individuals with mental illness, mental illness and substance abuse in the U.S. 
 
Reprinted from SAMSHA.gov, 2014 
                                                          
1 Reprinted from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Copyright 
2013. American Psychiatric Association. 
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Substance abuse treatment costs the American society over one half-trillion dollars 
annually and apart from the budgetary cost of substance use, the societal cost of substance use, 
abuse, and dependence is one of the leading causes of harmful and destructive behaviors (NIDA, 
2009).   The overwhelming societal and budgetary cost of substance use, abuse and dependence 
has resulted in a driving need to create programs to prevent substance abuse, addiction and 
relapse.  In order to provide better treatment outcomes there is also need to improve the 
effectiveness of programs that provide services for patients with dual diagnosis. 
Dual diagnosed patients have more illnesses and consequences from substance abuse in 
comparison to individuals diagnosed with only mental illness, like depression or schizophrenia.  
Illnesses and consequences that arise in this population include inpatient psychiatric 
hospitalization, increase in aggressive and violent behaviors, medication noncompliance, and 
greater exacerbation of psychiatric symptoms (Bogenschutz, 2013).   -Dually diagnosed 
individuals are also at a higher risk for co-morbid illnesses, substance abuse relapse, suicidal 
ideation, violence, incarceration, homelessness, HIV infection, and increased familial problems 
(Drake, et al., 1998).  Table 1 below shows a higher prevalence of medical conditions in 
substance abusers versus a control group (SAMSHA, 2005) 
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Table 1: Prevalence of Medical Condition in Substance Abusers vs. Controls
 
Individuals with dual diagnosis are often complex to treat, often requiring intense 
treatment (SAMSHA, 2005).  There are currently no diagnostic criteria for dual diagnosis in the 
DSM-IV-TR. (DSM, 2013).  Due to the complexity of treating dual diagnosis it would be helpful 
for providers to have a standardized diagnostic criterion for this diagnosis for clinicians to 
adequately diagnose and treat this population.   
The treatment of dually diagnosed patients from the 1980s to the mid-2000s consisted of 
treating solely the mental health disorder or the substance abuse disorder.   That treatment 
resulted in low success rates, which prompted the National Institute of Mental Health (NIMH), 
National Institute of Drug Abuse (NIDA), National Institute on Alcohol Abuse, and Alcoholism 
(NIAAA) to provide recommendations concerning integration of treatment for this population 
(Drake, et al., 1998). Integration of treatment is concurrent delivery of mental health and 
substance abuse treatment at the same time (SAMSHA, 2005). 
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Table 2. Rates of Treatment by Type (Mental Health, Substance Abuse) and  
by Severity Level of the Disorder (NCS-R) 
Level of Substance 
Abuse Disorder 
Type of Treatment 
Level of Mental Disorder 
12-month serious 
mental illness 
12-month other  
mental illness 
12-month substance 
dependence 
Neither MH nor SA 29% 71% 
MH only 49% 25% 
SA only 3% 1% 
Both MH and SA 19% 4% 
12-month substance 
abuse 
Neither MH nor SA 51% 78% 
MH only 49% 19% 
SA only 0% 0% 
Both MH and SA 0% 3% 
(SAMHSA, 2002) 
Table 2 above provides valuable information about data that resulted in the creation of 
DDCAT index for the treatment for individuals with dual diagnosis. The 2002 data shows that 
among individuals with 12-month substance dependence, those with both substance dependence 
and serious mental illnesses, only 19 percent of those with serious mental illness received 
treatment for both disorders; 29 percent did not receive treatment for either problem. If treatment 
was received at all, it most often was for the mental disorder alone (49 percent). The pattern was 
similar for individuals with other (not serious) mental illnesses. Disturbingly, among the 
individuals with substance abuse, the focus of treatment is mental health (49% of those with 
serious mental illness and 19% of those with other mental illness) instead of integrated care or 
even substance abuse treatment alone.  This table demonstrates the need to utilize evidence-
based models in the appropriate treatment of patients with dual diagnosis. 
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The Substance Abuse Mental Health Service Administration (SAMHSA) reports that the 
provision of integrated mental health services to patients with dual diagnosis in all settings has 
been recognized by Congress as an expectation, rather than an exception (SAMHSA, 2002). 
Research conducted with different mental health populations, including adults with severe and 
persistent mental illness, teens, and families that have been referred by the criminal justice and 
legal system, provide evidence for the benefits of combination, coordination and integration of 
single treatment strategies into treatment strategies that address dual diagnosis to improve 
treatment outcomes (Mueser, et al., 2003). 
The Dual Diagnosis Capability in Addiction Treatment (DDCAT) Index was developed to 
help agencies assess capability/readiness for dual diagnosis treatment due to the increasing 
recognition of the limitations of existing service settings.  It was developed specifically for 
addiction treatment service settings. Prior to the development of the DDCAT index, addiction 
treatment services for the dually diagnosed utilized a mixture of evidence-based practices and 
consensus clinical guidelines to guide their practice.  The DDCAT is the only objective measure 
available to guide the process of treatment integration to enhance treatment outcomes.   
The development of DDCAT was sponsored by SAMHSA and was designed to eliminate 
many of the disadvantages of traditional sequential and parallel treatment (SAMHSA, 2005). 
Mueser and colleagues (2003) have outlined several disadvantages of sequential treatment 
including the following: when there is an untreated disorder, the treated disorder worsens; it is 
impossible to stabilize one disorder without attending to the other; there is a lack of agreement to 
which disorder should be treated first,,  it is unclear when one disorder has been “successfully 
treated” so that treatment of the other disorder can commence, sequential treatment is negatively 
associated with referral of the client for further treatment (Mueser, et al., 2003).  Parallel 
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treatment also has several disadvantages.  When providers follow the parallel treatment 
paradigm, mental health and substance abuse treatments are not integrated into a cohesive 
treatment package.  Treatment providers fail to communicate, the burden of integration falls on 
the client, and funding and eligibility issues create barriers to treatment.  In addition, in parallel 
treatment, different treatment providers may have incompatible treatment philosophies and lack a 
common language and treatment methodology; clients may be more likely to slip between the 
cracks and receive no services due to failure of either treatment provider to accept final 
responsibility for the client (Mueser, et al., 2003). 
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CHAPTER 2: DESCRIPTION OF THE DDCAT INDEX 
The DDCAT Index is a benchmark instrument developed in 2003 by psychiatrist, Dr. 
Mark McGovern, to evaluate the capability of an addiction treatment program to provide services 
for dual diagnosis patients. He developed the DDCAT in response to a report released to 
Congress in 2002 on the “Prevention and treatment of Co-occurring Substance Abuse Disorders 
and Mental Disorders” (SAMSHA, 2002).  The report addressed recent research that noted the 
effectiveness of integrated treatment and the presence of evidence based treatment practices that 
needed to be implemented in programs for effective treatment outcomes.  The DDCAT was 
developed to enhance treatment outcomes in substance abuse and addiction programs.   In 
addition, addiction treatment agency providers requested for specific guidance on ways to create 
or enhance integrated services for their programs.  
The DDCAT is an objective tool which has rated scales following a site visit that includes 
semi-structured interviews with staff at all levels, review of program documents, client charts, 
and observation of the milieu and setting.  It provides specific suggestions and examples from 
the field on how to reach Dual Diagnosis Capable (DDC) level services which means that the 
program is capable at a dual diagnosis level and is capable of treating individuals with mental 
health disorders that are stable.   Likewise, programs already assessed at the DDC level have 
asked for specific guidance on how to attain the Dual Diagnosis Enhanced (DDE) level which 
refers to the program being capable to treat individuals with acute and unstable mental health 
disorders.   
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The DDCAT index is based upon a fidelity/adherence assessment methodology. This 
methodology is a valid method used to measure a program’s adherence to and competence in the 
delivery of recommended evidence-based practices (Mueser, et al., 2003). The need for fidelity 
scales to effectively measure these integrated treatment programs is essential for clients, families 
of clients, investors, treatment providers and government organizations in order to determine 
what modalities of treatment are most effective for this population and which evidence based 
programs and practices yield the most positive treatment outcomes.  Psychometric properties and 
indices of inter-rater reliability, internal consistency, convergent and discriminate validity, 
preliminary criterion validity, and sensitivity to change support the use of the DDCAT (DDCAT, 
2011). 
The index was initially field-tested in Connecticut, Louisiana, and New Hampshire 
before its implementation in various other states, Native American tribes, and internationally. 
There was a revision of the DDCAT items and scoring anchors in 2006 and 2011.   The updated 
version will be used in the evaluation of the community based substance abuse agency.   
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Table 3: Domains and Elements of DDCAT index. 
Domain Elements 
1. Program Structure IA. Mission Statement 
IB. Organizational certification & licensure. 
IC. Coordination and collaboration with mental health 
services 
ID. Financial incentives. 
2.  Program Milieu IIA. Routine expectation of and welcome to treatment 
for both disorders. 
IIB. Display and distribution of literature and patient 
educational materials, 
3.  Assessment IIIA. Routine screening methods for psychiatric 
symptoms,  
IIIB. Routine assessment if screened positive for 
psychiatric symptoms,  
IIIC. Mental Health and Substance Use diagnosis 
IIID. Mental Health and Substance Use History 
Reflected in Record 
IIIE. Program Acceptance Based on Psychiatric 
Symptom Acuity 
IIIF. Program Acceptance Based on Severity of 
Persistence and Disability 
IIIG. Stage-Wise Assessment 
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4. Treatment  IVA. Treatment Plans, 
IVB. Assess and monitor interactive courses of both 
disorders; 
IVC. Procedures for psychiatric emergencies and crisis 
management 
IVD. Stage-wise treatment ongoing  
IVE. Policies and procedures for medication 
evaluation, management, monitoring, and compliance, 
IVF. Specialized interventions with mental health 
content, 
IVG.  Education about psychiatric disorder and its 
treatment, and interaction with substance use and its 
treatment, , 
IVH. Family education and support 
IVI. Specialized interventions to facilitate use of dual 
diagnosis self-help group,  
IVJ. Peer recovery supports for patients with MH 
5.  Continuity of Care VA. Co-occurring disorder addressed in discharge 
planning process  
VB. Capacity to maintain treatment continuity  
VC. Focus on ongoing recovery issues for both 
disorders  
VD. Facilitation of self-help support groups for Co-
occurring disorder (COD) is documented  
VE. Sufficient supply and compliance plan for 
medications is documented.   
6. Staffing VIA. Psychiatrist or other physician  
15 
 
VIB. On site staff with MH licensure (doctoral or 
masters level),  
VIC. Access to mental health supervision or 
consultation.  
VID. Supervision, case management, or utilization 
review procedures emphasize and support COD 
treatment   
VIE. Peer/Alumni supports are available with COD   
7. Training VIIA. All staff Members have basic training in 
prevalence, common signs and symptoms, screening 
and assessment for psychiatric symptoms and 
disorders,  
V11B. Clinical Staff Members Have Advanced 
Specialized Training in mental health and substance 
use disorders, including pharmacotherapies.    
 
The DDCAT index evaluates a program in 35 elements subdivided into 7 domains (Table 
3).   Program Structure focuses on general organizational dimensions that foster or inhibit the 
development of integrated treatment. The Program Milieu dimension focuses on the culture of 
the program and whether the staff and physical environment are receptive and welcoming to 
persons with co-occurring disorders. Clinical Process dimensions (Assessment and Treatment) 
examines whether specific clinical activities achieve specific benchmarks for integrated 
assessment and treatment. The Continuity of Care dimension examines the long-term treatment 
issues and external supportive care issues commonly associated with persons who have co-
occurring disorders. The Staffing dimension examines staffing patterns and operations that 
support integrated assessment and treatment. The Training dimension measures the 
16 
 
appropriateness of training and supports that facilitate the capacity of staff to treat persons with 
co-occurring disorders.  
The DDCAT categorizes programs into three different levels of services: (1) Addiction 
only services (AOS): the program is capable to offer services at an addiction only service level.  
The program does not accommodate individuals with mental health disorders. (2) Dual 
Diagnosis Capable (DDC): the program is capable of offering services at a dual diagnosis level 
and is capable of treating individuals with mental health disorders that are stable in addition to 
addiction services.   (3) Dual Diagnosis Enhanced (DDE): the program can treat individuals with 
acute and unstable mental health disorders and addiction disorder.     
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CHAPTER 3: CONCEPTUAL AND THEORETICAL FRAMEWORK 
            The DDCAT framework is based on the conceptual framework of the taxonomy of 
addiction treatment services outlined by the American Society of Addiction Medicine (ASAM) 
(ASAM Patient Placement Criteria Second Edition Revised (ASAM-PPC-2R, 2001) and on the 
theoretical framework of the Trans Theoretical Model of Behavior Change (TTM) also referred 
to as stages of change theory (Hansen, et al., 2008).   SAMSHA determined that a need existed to 
classify organizations that treated dually diagnosed individuals according to capability ratings.    
ASAM developed the conceptual framework taxonomy to classify the dual diagnosis capability 
of addiction, which includes three categories of capability: Addiction only service (AOS), Dual 
diagnosis Capable (DDC), or Dual Diagnosis Enhanced (DDE).  The DDCAT utilizes the 
categories outlined by ASAM and incorporates fidelity assessment methodologies, which are 
observation methods and objective metrics to ascertain the dual diagnosis capability of addiction 
treatment services: AOS, DDC, or DDE.  
 The DDCAT framework is based on the Trans Theoretical Model of Behavior Change 
(TTM) outlines Prochaska and Diclemente, (1983) change theory and Mezirow’s Trans 
formative theory.  It outlines enhanced services by anticipating an organization’s likelihood of 
behavioral change.  The TTM has been used by various agencies and institutions to facilitate 
behavior change.  This validated model is used in many substance abuse treatment programs.  
According to Hansen et al. (2008) the Trans theoretical model of change and Tran’s formative 
theory of learning are demonstrative of the process of organizational structure change.   The 
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DDCAT index resulted as a response to addiction programs that were in the action phase of 
readiness.   It offers practical, useable materials to enhance services for the dually diagnosed.  
Focused Evidence Appraisal of DDCAT Use in Agencies 
               A number of studies have utilized the DDCAT to evaluate programs that provide 
services for individuals with dual diagnosis (Drake, et al., 1998). These studies demonstrate that 
the DDCAT can be feasibly used to evaluate barriers and facilitate agency capability (Drake, et 
al., 2001). What follows is a brief description of five studies that have implemented the DDCAT 
evaluation in various settings. 
                One team of researchers studied 30 treatment programs using the DDCAT in two 
California counties. Seven of the programs received funding to provide both mental health and 
substance use disorder services, 13 received funding to provide mental health services, and 10 
received funding to provide substance use disorder services. The study addressed the programs’ 
capacity to meet the needs of clients with dual diagnosis, identified areas where they were well 
equipped to serve these clients, and determined where improvement was needed. The study also 
evaluated the impact that funding sources had on the capability of program services for the 
dually diagnosed.  Programs that received funding to provide integrated care were found to 
consistently score higher in DDCAT scores than the other programs that did not receive such 
funding.  The investigators found that program structure and staff training were the DDCAT 
domains that required the most improvement for endorsement for dual diagnosis capability, 
while staff training was the highest endorsed priority area for improvement; program structure 
was the lowest priority.  In addition, mental health programs scored higher than addiction 
treatment programs in most DDCAT domains and the overall assessments (Padwa, Larkins, 
Crevecoeur-MacPhail, Grella, & Christine, 2013).   
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In another study, the DDCAT was used to examine 185 state-licensed outpatient 
substance abuse clinics to evaluate their capability in delivering integrated services for 
individuals with dual diagnosis (Chaple, Sacks, Melnick, McKendrick, & Brandau, 2013). Client 
retention and the relationship with capability scores were measured.  There was a significant 
positive relationship between DDCAT scores and client retention.  The results indicate that 
programs with high DDCAT scores had greater length of stay and better treatment outcomes.  
Screening/assessment and treatment were the only dimensions unrelated to the length of stay of 
patients in addiction programs.  Program structure, program milieu, treatment, continuity of care, 
staffing and training were related to length of stay (Chaple, et al., 2013).  
Researchers in Australia utilized the DDCAT to examine the   program manager’s 
perceptions for change after the completion of the DDCAT; they also examined the usefulness of 
the DDCAT in two residential substance abuse programs.  Sixteen residential substance abuse 
units were examined using the DDCAT by an external researcher.  The researchers reported 
positive attitudes towards use of the DDCAT and were confident that their unit could improve 
their DDCAT scores (Matthews, Kelly, Deane, & Frank, 2011).    
Another team of researchers surveyed 453 addiction treatment providers who were asked 
to identify their program as Addiction Only Services (AOS), Dual Diagnosis Capable (DDC) or 
Dual Diagnosis Enhanced (DDE). The survey also queried providers on prevalence estimates, 
clinical practices, and perceived barriers to treating persons with co-occurring substance use and 
psychiatric disorders.   The providers were provided brief definitions of the services, 92.9% of 
providers surveyed categorized their program as: AOS (23.0%), DDC (65.3%) or DDE (11.6%). 
The program dual diagnosis capability varied by characteristics of the patient, clinical practices, 
and barriers to effective treatments.  The findings support the utility of the ASAM dual diagnosis 
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capability taxonomy, and suggest specific avenues for system and program assessment and 
future research (McGovern, et al., 2007).  
Similarly, a set of researchers examined eighty-six programs, 54 addiction treatment 
programs  and 32 mental health treatment programs at baseline and 18-month follow-up using 
the DDCAT index.  The researchers examined implementation factors associated with addiction 
and mental health treatment program improvement in services to persons with co-occurring 
substance use and psychiatric disorders. The study had two primary aims: 1. to articulate factors 
associated with successful program change and 2. to determine whether the effective factors are 
different by program type.   
During follow-up, program leaders were surveyed about implementation factors that may 
have accounted for changes in capability. The results showed that both addiction and mental 
health programs significantly improved dual diagnosis capability during the study period. Factors 
associated with positive change in addiction treatment programs included organizational and 
contextual components, use of the commonly recommended implementation strategies, and 
deploying evaluation methods.  The study concluded that both mental health and addiction 
treatment programs can enhance dual diagnosis capable services through a variety of 
implementation approaches (McGovern, 2007b). 
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CHAPTER 4: PROJECT PURPOSE AND RATIONALE 
The report to the United States Congress in 2002 identified an increased need to address 
individuals with dual diagnosis and an inadequate utilization of evidence-based models in 
treatment programs for patients with dual diagnosis (SAMSHA, 2002).  This resulted in 
undesirable consequences, which include inpatient psychiatric hospitalization, increase in 
aggressive and violent behaviors, medication noncompliance, greater exacerbation of psychiatric 
symptoms, and poor personal hygiene (Bogenschutz, 2013).  Programs that offer integrated 
services that adhere to evidence-based principles are more likely to produce desired treatment 
outcomes such as medication compliance, lower relapse rates and control of psychiatric 
symptoms (Torrey, et al., 2002).  Therefore, SAMSHA recommendations are for programs that 
offer dual diagnosis services to provide integrated care to patients (SAMSHA, 2002).  
The DDCAT is the only evaluation tool produced and endorsed by SAMHSA to assess an 
agency’s capability for providing integrated services to dually-diagnosed individuals.  The 
assessment with the DDCAT categorized the agency according to Addiction only service (AOS), 
Dual diagnosis Capable (DDC), or Dual Diagnosis Enhanced (DDE).  There has been limited 
research on the use of the DDCAT index to determine the capability of integrated dual diagnosis 
care in community-based health centers that include substance abuse and mental health 
programming.  
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The purpose of the project was to use the DDCAT index to evaluate an existing CBHA 
that provides mental health and substance abuse service to dually-diagnosed clients.  The 
DDCAT index was used to identify the capability of the agency to provide integrated services to 
the dually diagnosed and the findings were used to recommend changes that could be made to 
enhance services and programs to facilitate the improvement of treatment outcomes.    
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CHAPTER 5: TARGET SITE/PARTICIPANTS 
CAARE, Inc. is a grassroots, non-profit organization in southeastern United States that 
promotes a holistic and community approach to health. CAARE, Inc provides a wide variety of 
services that help treat not only the medical roots of chronic diseases, but also the social and 
human factors that contribute to these health deficits. CAARE, Inc seeks to address disparities in 
health care access, and over the past nineteen years has created a community devoted to helping 
people make all parts of their lives healthier. CAARE, Inc. began as a non-profit community 
based provider of supportive services for individuals living with HIV/AIDS and their affected 
families.  The goal was to support, educate and empower the HIV/AID community and high risk 
populations.  The expanded goal is the promotion of a healthier Durham community through a 
holistic program to help decrease a broad range of health disparities that are affecting global 
health.  The five health disparities include cancer, cardiovascular disease, diabetes, obesity and 
HIV/AIDS.  These five health disparities have become CAARE, Inc’s primary healthcare service 
focus areas. 
The holistic program addresses additional specific programmatic areas including Case 
Management, Substance Abuse Treatment, VA Traditional Housing and the Jeanne Hopkins 
Lucas Education and Wellness Free Clinic Center.  Each of these projects maximizes positive 
healthcare results.  The HIV/AIDS program also provides a food pantry, community outreach, 
free education on HIV/AIDS and other STDs, free one-on-one consultation and risk reduction. 
The Outpatient Substance Abuse Treatment Program includes the Substance Abuse 
Comprehensive Outpatient Treatment (SACOT) and the Substance Abuse and Mental Health 
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Services Administration (SAMHSA).  These not only provide individual and group therapy 
sessions but also random and ongoing urine drug screening, referrals to psychiatric evaluations, 
relapse prevention group sessions, crisis contingency planning and DWI Outpatient Treatment 
for 20 and 40 hours.  The services implemented by CAARE, Inc‘s SACOT and SAMHSA have 
been life-saving interventions for  many who lack financial resources for most needed healthcare 
services. 
The Mental Health Program includes psychotherapy for individuals, couples, and 
families.  CAARE, Inc. also provides psychotherapeutic medication management, depending on 
individual patient needs and preferences.  In addition, the mental health program includes 
aftercare relapse prevention psychotherapy groups (Enlightenment Recovery Group) for 
graduates of the 16-week comprehensive outpatient substance abuse program.  The mental health 
program at CAARE, Inc. incorporates holistic strategies with psychotherapeutic techniques, 
including mindfulness and an appreciation for the contribution of good quality nutrition, sleep, 
living environments, healthy relationships, and spiritual fulfillment to optimal mental health and 
well-being.  The mental health program incorporates compassion and cultural sensitive 
approaches; clients are encouraged to identify their strengths and heart’s desires to facilitate goal 
attainment and life satisfaction.   
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CHAPTER 6: METHODOLOGY 
 The project followed the guidelines included in the DDCAT index toolkit which had 
instructions on the scoring of the different program domains and categories.   The scoring was 
based on observation, interviews with agency staff members and consumers, and review of 
documentation for the purpose of data collection according to DDCAT index. Observations of 
physical milieu, physical structure and two group programs, the SACOT program and the 
Aftercare program were done using criteria outlined in the DDCAT index.  
  Staff members and clients were interviewed with questions that were outlined in the 
DDCAT index under the seven domains.   Interviews were conducted with the executive 
director, the substance abuse program director, the mental health program director, a certified 
care support specialist, a Certified Substance Abuse Counselor intern (CSACI), the licensed 
clinical social worker, and two randomly selected clients from the SACOT program and aftercare 
programs.    
The review of documents was done with outlined instructions from the DDCAT index .   
Five active charts and five discharged charts were reviewed from the SACOT program.  Five 
active charts and one discharged patients’ chart were reviewed from the mental health programs.    
Observational Approach  
 Observational methods were used to gather information about the substance abuse and 
mental health programs and rate its status regarding dual diagnosis capability. The following 
areas were observed and were used for data collection: observations of the milieu and physical 
setting, observations of the substance abuse comprehensive outpatient treatment program 
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(SACOT), and observation of the Aftercare substance abuse program.   Observation of the milieu 
and physical setting was done during tours of the facility, while the SACOT and Aftercare 
programs were observed on two different days for an entire days’ session according to the 
DDCAT index.  
Interviews with Agency Staff members and consumers  
 Interviews/conversations with the agency director, substance abuse director, mental 
health director/psychiatric nurse practitioner, substance abuse counselor, and consumers were 
done to gather information about the mental health and substance abuse programs and rate their 
dual diagnosis capability.  Interviews lasted approximately one hour, and were conducted onsite.   
Interview questions followed the guidelines included in the DDCAT index toolkit which had 
outlined questions for agency director, clinicians and consumers.   Answers to the questions were 
used to score and rate the different program domains and categories. 
Review of Documents 
 Documents reviewed included brochures, policy and procedure manuals, patient activity 
schedules, and other pertinent materials to score the DDCAT index.   Copies of documents were 
obtained to review ahead of time.  Five charts of active clients and discharged clients from the 
substance abuse program were reviewed.  Five charts of active mental health client and one 
discharged client chart was reviewed for the mental health program.   
DDCAT Process/Procedure 
 The DDCAT process included key benchmark activities that were performed before and 
during the utilization of the DDCAT.  Prior to the utilization of the DDCAT there was an 
identification of a contact person/agency leader, a definition of the scope of the assessment, and 
a clarification of the time allocation requirements.  During the utilization of the DDCAT index 
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observation, interviews and review of documents were done according to criteria outlined in the 
DDCAT index.   
 The initial meeting with the agency director was scheduled to convey the purpose of the 
assessment and to relay any implications of the data being collected.  Other scheduled meetings 
included: agency tour and introduction to agency staff, data collection interviews with designated 
agency staff and consumers, and an “exit” feedback meeting with the agency director and staff 
members including: Executive director (agency director), SA Director/Intake Coordinator, SA 
facilitator/Peer Support Specialist, SA facilitator/Peer Support Specialist, Mental Health 
Director/Psychiatry Mental health Nurse Practitioner, SA Office Assistant/Volunteer, and MH 
Office Assistant/Volunteer.  
 An initial meeting with the contact person/agency director was conducted to discuss the 
project and to receive formal approval of the methodology.  A second meeting was conducted 
with the contact person/agency director to gather descriptive information about the program to be 
listed on the DDCAT rating scale cover sheet.  This was used in tabulating, and making 
comparison of DDCAT scores.   The information provided in the second meeting was used to 
provide a format to organize basic information and provide the agency with information 
regarding data sources used and the assessment process. Next, a meeting was scheduled to allow 
the contact person/agency director to introduce the evaluator to the agency staff, describe the 
project goals to the staff, and schedule days and times to complete the formal site visit and 
evaluation using the DDCAT index.   The next step involved a formal tour of the program 
physical site.  This was done for re-introduction of staff to the project, observation of the milieu, 
to meet additional staff and consumers, and have conversations with them to collect data as 
outlined in the DDCAT index.  The data collection and the formulation of the findings were 
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completed over five months, and feedback was provided to the contact person/agency director 
and the staff.   
Procedure Timeline 
The evaluation took five months. The sequence of activities is shown below.  
• Month 1 (July 2014): IRB Submission and Approval 
• Month 2 (August 2014): Site Visit/Data Collection; print DDCAT assessment packets, 
implement DDCAT Index tool kit. Interview the staff and patients • Month 3 (September 
2014): Data analysis and interpretation of findings  
• Month 4 (October 2014): Reporting of oral results to agency  
• Month 5 (November 2014):  Submission of written project to agency 
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CHAPTER 7 
: OBSERVATIONAL FINDINGS 
Observations of Physical Milieu and Physical Structure 
 CAARE, Inc. is housed in downtown Durham, NC and consists of three buildings; a large 
two level brick building, which serves as the main office building and two smaller houses behind 
the brick building.  In the main office building the main level houses staff offices, a board room, 
a non-denominational chapel, CAARE, Inc. economic incubator center, mental health 
counseling, the CAARE, Inc. outreach program, the GED Program/Computer training Center, 
the event center and for the Kids Club room.   The second level (downstairs from the main level) 
houses the Wellness Center which encompasses treatment space for Reiki, the massage therapy 
center, auricular acupuncture center, a fitness room with weights and cardiovascular equipment, 
the medical clinic, and the dental clinic.  On the lower level of the main building there is also a 
fifteen bed veteran’s dormitory. Behind the main brick building is a green house, above ground 
garden beds, a large rain water harvesting tank, and space for the creation of an apothecary 
garden.  In addition there is a house that is under renovation to eventually become a dormitory 
for women and a substance abuse and recovery club house.  Most of the substance abuse 
treatment group meetings are held in the club house.    
 The main office building has a waiting room with comfortable chairs lining the walls and 
a reception area in the middle of the waiting area with a receptionist who welcomes visitors, 
patients or staff.  The receptionist also answers all phone calls.  The walls are covered with 
pictures and posters.  One wall has various licenses, certifications, and awards that have been 
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presented to the center: CARF (Commission on Accreditation of Rehabilitation Facilities) 
international 3 year accreditation for healing with CAARE, Inc., a license for adult intensive 
outpatient treatment for alcohol and other drugs, a license for outpatient treatment of alcohol and 
other drugs/addiction (adults), a Department of Health and Human Services (DHHS) certification 
for the provision of  substance abuse services for individuals who have been charged with 
driving while impaired offender, an a mental health facility license, a certificate of collaboration 
with the Durham Center, and a business certification.  A brochure stand sits at the corner of the 
waiting area with AA and NA materials and meeting schedules, along with pamphlets on 
HIV/AIDS, and state employment and financial assistance services.  Another waiting area has a 
bulletin board that has an announcement for Zumba dance, line dance and various other 
activities.  
Observation of SACOT group 
The SACOT group is held on weekdays from 9am-1pm for sixteen weeks.  It is primarily 
a substance abuse recovery/treatment group.   Patients have to commit to attend all groups and 
maintain sobriety.  The group is held on site in the clubhouse.   The group is facilitated by two 
certified peer support specialists (CSAC).   They utilize the Matrix Model manual for each of the 
classes.   It is a closed group.   Group rules are posted on the walls of the class.  The class begins 
with a sign-up sheet and introduction of the lesson and activity for the day.   Participants are 
invited to ask questions.   There is open interaction between facilitators and participants.   
Participants are aware of the rules and respectful of others.   The facilitator ensures that everyone 
in the group is participating by calling on different individuals to answer questions or summarize 
the lesson.   During my visit to the group, the day’s lesson was on addictive behavior and 
participants were handed out copies from the Matrix manual that showed different kinds of 
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behaviors:  participants had to pick which of the behaviors are related to their drug or alcohol 
use.    Participants were given ten minutes to finish the activity.    This followed up with an 
interactive discussion between facilitator and participants.   Participants appeared to enjoy the 
interaction and provide feedback to facilitator.   The class ended up with an invitation to lunch 
for all participants (Note: a hot meal is served for lunch after each SACOT class).     
Observation of Aftercare Program 
The aftercare program is a relapse prevention outpatient program that takes place onsite 
at CAARE.   It is an open group to graduates of the 16-week SACOT program.   It is facilitated 
by the PMHNP who is also the mental health program director.   Participants are encouraged to 
be open and interactive.   On the day of observation participants were welcomed to the group and 
the facilitator summarized the group rules.   The facilitator made the group aware of what the 
activity was for the day.   A handout for the activity was given out titled: enlightenment 
continuing recovery group.  The activity was for participants to reflect upon the past week and 
what activities they engaged in each day to enhance their success in recovery.   Participants were 
given ten minutes to finish the activity.   There was open discussion following the activity, and 
then participants were instructed to reflect on whether they would do the same activity this 
present week or something different.   Participants were instructed to write out their plans for the 
present week in the second row of the handout.   After the activity was completed there was open 
discussion and interaction.   The group session concluded with reading the daily text from the 
twelve steps: the ninth step-reclaiming life and everyone reciting the serenity prayer.      
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CHAPTER 8: INTERVIEW FINDINGS 
Interview of Executive Director  
The executive director has a PhD in divinity and is a master’s prepared registered nurse.  She 
describes the program as a substance abuse and mental health not-for profit, outpatient program. 
She reported that although the program is not called a dual diagnosis program it is licensed to 
provide substance abuse outpatient and mental health services, and is funded by Medicaid.  She 
reported that the primary focus of the agency is addiction treatment services, mental health 
services and general health services.  The agency offers a sixteen week substance abuse 
comprehensive outpatient treatment program (SACOT), HIV case management, VA housing, job 
training program/job links, substance abuse aftercare program, GED classes, computer classes, 
benefits aid eligibility for Medicaid, a food pantry, massage therapy, acupuncture therapy, a 
service club for children (Kids club), a library, coffee shop, a gym, a free medical and dental 
clinic, and the clinic educational wellness center.  She estimates that the substance abuse 
program had 100 admissions in the last fiscal year, 120 serviceable capacity, and a 20 week 
average length of stay, a 16 weeks planned length of stay, and 100 unduplicated clients per year.  
The programs are exclusively for adults on an outpatient basis. 
Interview of the Substance Abuse Program Director 
The substance abuse program director is a licensed substance abuse specialist (LSAC) 
who reported that the agency is licensed to provide both mental health and substance abuse 
treatment.  An initial screening is done by phone or in person that ascertains if the person has had 
prior substance abuse treatment, their last use, and their drug of choice. She gives the assessor a 
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copy of the intake packet which includes a bio-psychosocial evaluation, a brief mental status 
section, along with a series of questions about both substance use and treatment histories, and 
similar questions about mental health symptoms and treatment. The form also asks if the 
individual is currently on any psychiatric medications, and if so, which ones. She reported that 
when a patient is identified at screening with a mental health disorder a referral form is filled out 
and sent to an in-house psychiatric nurse practitioner who follows up with a phone call to make 
an appointment with the patient, and after seeing the patient generates a mental health patient-
centered care plan.  She reported that she also generates a treatment plan with a focus on 
substance abuse treatment.    
The patients are referred to the agency through different sources: Alliance, Durham crisis 
center, hospitals, the judicial system, alcohol and drug treatment centers, other agencies, the 
court, and others are self-referrals.  All patients are admitted to SACOT if they have a substance 
abuse diagnosis. She estimates that sixty percent have dual diagnosis, but admits that there is no 
record of dual diagnosed patients.  The evidence-based Matrix Model client handbook is used as 
the teaching tool in the SACOT program.  There are no posters or videos used for teaching.  The 
Beck Depression Scale and alcohol standardized screening forms are used during the intake 
process.  She estimates that 60% of the program’s 160 clients have co-occurring disorders. When 
asked if there are any admission restrictions, she answered in the negative, stating that “everyone 
is welcome.”   
She reported that CAARE, Inc was created to meet the community’s needs; therefore not 
everyone that comes in will have a mental health or substance abuse diagnosis, but may need 
food or referral for shelter.   She reported that for individuals who are admitted to the substance 
abuse comprehensive outpatient treatment program (SACOT), the program policies require 
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individuals to have a primary substance use disorder for licensing and billing reasons. Although 
the program attempts to accommodate “everyone,” they are selective with patients with a co-
occurring mental health disorder, and will refer them to the local mental health clinic if they are 
noted to be unstable with active psychosis.   That practice is not in writing; however, she 
reported the program will admit individuals with a co-occurring mental health disorder if they 
are stable on their medications.  
She reported that the policy does not formally exclude any population, but sometimes 
will exclude sex offenders or anyone mentally unstable.  Although the Program Director reported 
the agency welcomes everyone, she reported that the SACOT program is not always the best fit 
for individuals with active psychotic disorders and that they keep an eye out for medications that 
would indicate this. These individuals are referred to the local mental health clinic. Individuals 
who are suicidal or homicidal are likewise not admitted. When asked about any specialized 
interventions for individuals with co-occurring disorders, the Program Director reported that 
there are no specialized programs.  She reported that the substance abuse is facilitated by two 
certified peer support counselors who recently completed workshop in motivational 
interviewing. 
When asked about staff training, she reported that due to financial constraints, the agency 
does not have any formal, in-house staff training programs for substance abuse,  Training is done 
online or staff go voluntarily for free training.  She reported there is no set program training plan. 
Staff are allowed time off to go to training conferences.   She reported that the facilitators of the 
substance abuse have a good understanding of co-occurring disorders and typically sign up for 
new co-occurring trainings provided online or off site.   
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The Program Director reported that there are no staff specialized in treating co-occurring 
disorders, but the intake person is an LCSW with a Master’s Degree in Social work, who has 
extensive experience in co-occurring disorders.   Two counselors are certified peer support 
counselors (CSAC) and are working on completing their Certified Addiction Counselor 
Credential from the State Certification Board.  She denies any formal training for clerical staff 
since they are not engaged in treating clients.  The Program Director indicates that she provides 
weekly individual supervision to all the facilitators and intake clinician.  She reported she 
operates on an open door policy and staff can come to her at any time.   The Program Director 
reported that the program has an onsite psychiatric nurse practitioner who sees the patients with 
co-occurring disorders.  Referrals to the nurse practitioner are done routinely when patients are 
identified with mental health problems. She reported that the psychiatric nurse practitioner 
renews prescriptions as needed for patients with co-occurring disorders.   She reported that not 
all the patient’s with co-occurring disorders are seen by the PMHNP, some are managed by the 
local health clinics or their private psychiatrist.  
The Program Director provided a tour of the agency pointing out the clubhouse for the 
SACOT program, and the rooms used for aftercare.  Graduates from the SACOT program are 
advised to continue to attend aftercare to assist with sobriety and prevent relapse.  The program 
director is not aware of any specialized referral to dual diagnosis programs.    
Interview of the Mental Health Program Director 
The mental health program director has a PhD in Social and Health Psychology and is a 
PMHNP.  When asked about the program structure she reported that the mental health services 
are provided through consultation from the SACOT program through a referral process.  She 
sees the patient onsite one and one-half days weekly with some informal integration with the 
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SACOT program.  She reported that starting recently this year, the SACOT and mental health 
services have begun use of a single treatment plan.  She adds an addendum to the treatment plan 
developed by the SACOT program.   She also develops her own treatment goals and updates it as 
necessary at each visit.   There is no formal treatment team meeting with the SACOT program 
due to her schedule; she can only be there twice weekly and devotes this time to patient care.   
She reported the program welcomes all patients.  Patients are self-referred or referred from the 
SACOT intake.   She schedules the patients for an evaluation; if she is not able to schedule in 2-4 
weeks she refers the patient out.   She estimates that the percentage of patients with co-occurring 
disorder is 75%-85%, but there is no formal documentation.   
She reported she does not routinely provide literature/educational materials to patients 
about substance abuse or mental health or their interaction, but will provide literature if clients 
request it.  She does not routinely use posters or videos during visits.  She used handouts mostly 
during the twice weekly aftercare sessions.  There are no documented admission limitations re: 
symptom acuity, or symptom severity but patients need to primarily stable on their medications.  
She reported that stages of change or motivational stages for MH and SA are not formally 
assessed during treatment.  Patients are not matched to formal stage-wise treatment frameworks.  
The program has documented procedures for psychiatric emergencies and crisis 
management which is given to the patient during admission.   It has a 24 hour business cell 
phone that is made available to the patients.  There are written guidelines including a standard 
risk assessment that captures MH emergencies and identifies intervention strategies.   A formal 
arrangement with Alliance Behavioral Health, the local management entity for behavioral health, 
is documented to help manage crisis situations.  There is a documented in-house crisis 
management guidelines and goals. 
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Pertaining to clinical treatment she uses specific therapeutic interventions/practices that 
target specific MH symptoms and disorders such as CBT, psychodynamic, interpersonal- 
(eclectic) – person centered.  The program addresses generic interventions (e.g. stress 
management, coping skills) informally during the aftercare program.  There are no specialized 
(e.g. manual-based) interventions for specific disorders, systematic adaptation of EBP addiction 
TX, or integrated EBP for COD.  She reported that the program provides generic education about 
MH disorders, treatment, and interaction with SUD; this is variably offered.  There is no 
curriculum used for aftercare.   Patients are not formally matched with individual peer supports 
and role models, but are aware that they can contact her at any time.  She makes her cell phone 
number available and the crisis line has peer support specialists available. There is no formal 
documentation in the treatment plan.  
Pertaining to family involvement in the client’s treatment process, she reports that there is 
no formal family involvement in the treatment process but she will involve the family at the 
request of the patient or will make a suggestion to involve the family if it seems appropriate.  She 
makes the patients aware that their families are welcome to their sessions.   She assists 
individuals with dual diagnosis to develop a support system through self-help groups using 
variable interventions, mostly to addiction peer support groups.  This is a generic on-site format.  
There is no intentional facilitation based on MH disorders. 
Pertaining to continuity of care, she reported that there is no formal or specialized method 
for interventions to facilitate use of community-based peer support groups but some patients 
have been referred to the local clubhouse programs for psychosocial rehabilitation. 
 During discharge planning patients are referred to the aftercare program which has no discharge 
date.   There is no documented philosophy of recovery for the agency or the client. 
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She manages and maintains medication planning and prescription renewal.  Most of her 
patients are not discharged from her care; she continues to provide routine 30-day medication 
supply; with typically three refills ordered.  She provides medication management services at the 
agency. 
Pertaining to staffing, she reported that program maintains staff and volunteers in 
recovery from dual diagnosis who can serve as peer/alumni supports, but there is no formal 
protocol to insure ongoing site supports.  She operates an open door policy and patients and staff 
have access to her.  She attends treatment team occasionally, but due to scheduling cannot be 
there all the time.  She receives supervision from a psychiatrist as outlined in her collaborative 
practice agreement, but also consults with her peers off-site as needed.  The primary focus for 
supervision and consultation is case disposition.  She reported there is no formal case/utilization 
reviews done to monitor appropriateness or effectiveness of services for dual diagnosed patients.  
In the event of a mental health emergencies or crises the written crisis protocol is 
followed.  She reported that the agency has had only four emergencies in four years.  When a 
client is noted to be decompensating and needing crisis management, a referral or transfer is 
made with the local behavioral health crisis center or911 emergency services are called.  
Interview of SACOT Counselor 
One facilitator of the SACOT program was interviewed.   She is a Certified Peer Support 
Counselor, (CSAC).   She reported that approximately 85% of the clients have dual diagnosis.  
She reported that clients are screened at intake by an intake specialist and referred to the 
PMHNP.  She does not know how that works.   She is mainly focused on facilitating the SACOT 
program.   The clients are required to attend the program daily from Monday to Friday for 
sixteen weeks from 9am to 1pm.  She uses the Matrix manual which is a recommended 
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substance abuse manual from SAMSHA to facilitate the class.  She reported that specific topics 
dealing with dual diagnosis are addressed during the sixteen weeks, and patients are advised to 
notify staff if they have symptoms and need further treatment.    Patients are taught about the 
interaction between substance abuse and mental health during the sixteen weeks.   Random drug 
test are done and patients that fail the drug test have to start the program over.   Patients are 
given handouts and encouraged to attend the local AA, NA group meetings.   An AA meeting is 
held every Wednesday and patients are required to attend.   She operates an open door policy and 
is very excited to be facilitating the classes.  She tells the participants about her recovery and is 
open about her diagnosis, which she believes helps the participants with their recovery.   She 
reported that although most of the clients are dual diagnosed their diagnosis does not affect their 
participation in the program.   However if a client is noted to be having issues she collaborates 
with the PMHNP for evaluation and recommendation.   She reported the PMHNP is always 
available by phone for consultation.   There are no formal scheduled meetings with the PMHNP.    
In regards to supervision, she reported that all counselors are supervised by the SACOT 
program director weekly.  There is a formalized treatment team meeting where personal care 
plans are developed.  She reported the program director is assessable for questions and 
interventions when needed.   They have weekly staff meetings where several clients are reviewed 
and updated.   Discharge planning is done from intake.    Patients are discharged to the aftercare 
program.   She reported that the program organizes a graduation for the clients after sixteen 
weeks.  Four graduations are held annually.  Patients look forward to the graduation.   Previous 
graduates return to be key note speakers during graduation. 
When asked about psychiatric emergencies or crises, she reported there is a protocol and 
guidelines for emergencies.   Patients are made aware of the crisis line at intake and throughout 
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the program.   In the event there is a crisis during class she will call 911 and seek for further 
help. 
When asked if she assesses for stage of change, she reported she uses her training in 
motivational interviewing, but there is no formal documentation that stages of change are 
evaluated.  She does not do any specific linking of clients to specific groups or individuals, but 
encourages clients to attend local groups and “work their steps” to stay in recovery. 
Interview of Consumer 
Two clients were selected and asked to be interviewed: one from the SACOT program 
and one from the aftercare program.  The client from the SACOT program reported that the 
program has helped him.  He has been in the program for four weeks.   He reported that the staff 
members in charge of the SACOT program are in recovery, which helps them identify with the 
clients.  He reported that “everybody knows everybody”.   He admits to being dual diagnosed 
and reported being diagnosed with depression.  He reported he is not aware of the agency’s 
mental health program or Aftercare program.  He reported that he has a local mental health 
provider that prescribes his medication.    He reported that family members are not allowed in the 
meetings.  He reported that he can talk with the counselors about anything when he calls them.   
He reported mental health issues are discussed during the classes and the counselors’ advise 
patients to continue to take their medications 
The individual interviewed from the mental health program admitted that she liked the 
program and everyone was nice to her.   She has been in the program for two and a half years.  
She graduated from the SACOT program and is presently is in the aftercare program.  She 
reported she occasionally volunteers in the SACOT program to encourage the participants.   She 
reported that the counselors encourage the participants to volunteer after graduation.   She is not 
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linked to anyone in the program with a co-occurring disorder.   She reported she does not think 
she is ready for that at this time.   She has an AA sponsor and she attends aftercare.   She 
reported she has no insurance but continues to be seen by the PMHNP.   All her medications are 
prescribed by the PMHNP.    She reported that mental illness is not discussed during aftercare 
and she would like to see it discussed more, because of the impact of mental illness on substance 
use and abuse.   She reported that mental illness is not a choice and feels that it should be 
discussed openly during the aftercare and SACOT meetings, because she feels most of the 
participants have mental illness.   She reported she is not given any dual diagnosis literature in 
the program, but gets literature from her sponsor and enjoys reading the substance abuse 
literature.  She reported that everybody does not come for the same reasons and therefore some 
people are more verbal than others.   She feels the center is a safe place and she enjoys going to 
groups or coming out to volunteer.   She reported that they are like a family. Aftercare keeps 
them connected to peers and help them feel personable.   She reported that the PMHNP that 
facilitates the aftercare has helped her tremendously in her recovery and mental health.   She 
reported that the PMHNP gives scenarios; draws on chalkboard which helps her understand her 
problems.  She reported she has attended various seminars in the program e.g. seminars on breast 
cancer awareness, coping with stress, and financial health.   She does not remember attending 
any seminar on mental illness.  She reported she continues to come to aftercare because she 
wants to stay plugged in.   She has spoken at past graduations about her experience in staying 
clean for two and half years.   
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CHAPTER 9: CHART REVIEW FINDINGS 
Chart Review of the SACOT program 
The charting system in the agency does not separate or distinguish dual diagnosed 
patients from addiction only patients, therefore charts were randomly selected.  A review of five 
active and five discharged client charts of the SACOT program indicated that a comprehensive 
substance abuse assessment is done on each client.  The program director had discussed the 
referral process indicating that clients were referred to a mental health program, but there was no 
referral form or indication in the ten charts  reviewed.   The comprehensive substance abuse 
assessment has a bio-psychosocial evaluation, which is completely filled out in all the charts, but 
information appears not to consistently match what is seen in the progress notes and personal 
care plan.   For example, one bio psychosocial evaluation showed the patient was not on 
medications, but a person-centered care plan mentioned that the patient’s medications would be 
monitored.   The person-centered care plans appear to be generic instead of addressing individual 
goals.    Mental health and substance use history and diagnoses are present in all the charts, but 
appeared to be contradictory in two charts where the bio-psychosocial evaluation showed 
different diagnoses compared to the treatment plan diagnosis.   Mental health and substance 
abuse history reflected inconsistencies in three active charts and two discharged patient charts; 
where patient’s records indicate that they were on several psychotropic medications.   Two active 
charts had a Beck depression screening tool while three charts had none.   Three discharged 
client charts had the Beck depression screening tool, while two did not have one.    All the 
patient charts had an alcohol screening tool.   
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All charts reviewed had a person-centered treatment plan with comprehensive and 
individualized goals.  The treatment plans addressed relapse prevention issues and goals for 
medication compliance.  Treatment plans in three out of five active charts addressed both mental 
health and substance abuse disorders.   Treatment plans in two out of four charts addressed both 
disorders even though all patient charts reviewed had dual diagnosis.   None of the charts had 
evidence of stage-wise treatment assessment or stage-wise treatment plan. Stage-wise treatment 
refers to treatment planning which is based on the patient’s readiness to change and level of 
treatment such as persuasion vs. active treatment; pre-contemplation; contemplation; action; 
maintenance (SAMSHA, 2011).   
Progress notes indicate sixteen weeks SACOT program requirement for relapse 
prevention and education about addiction using the matrix manual.  Although all charts reviewed 
included mental health diagnoses, there were no areas in charts that indicated (1) coordination 
and collaboration with mental health services, (2) assessment and monitoring of interactive 
courses of mental health and substance abuse disorders, or (3) specialized interventions with 
mental health content or education about mental health disorders.   Progress notes were focused 
on substance abuse relapse and education.  Progress notes did not indicate family education as 
part of treatment interventions or specialized interventions to use peer support groups.   
All ten charts reviewed had a generic discharge planning form attached.   The five active charts 
had no entries on the discharge planning forms since they were still active clients. The 
discharged clients’ charts were incomplete.  Dual diagnosis was not addressed in discharge 
planning process.  Clients’ capacity to maintain treatment continuity was not addressed on 
treatment forms. Focus on ongoing recovery issues for both disorders were not indicated on 
forms.  Facilitation to substance abuse support groups was addressed, but not addressed for 
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mental health in two charts.  Sufficient supply of meds, and confirmed follow-up appointment 
was not addressed in discharge plan.  Medications at time of discharge were on four out of five 
charts; all patients had medications at discharge according to comprehensive assessments.  All of 
the discharge plans include recommendations to regularly attend AA/NA meetings, obtain a 
sponsor, and attend the aftercare program. There was no documentation of confirmation of 
follow-up appointment or medication management, or refill of medications.   The program 
director had discussed the referral process indicating that clients were referred to a mental health 
program, but there was no referral form or indication in the ten charts  reviewed.    
Chart Review Mental Health Program 
  A review of five active and one discharged client charts of the mental health indicated 
that a comprehensive mental health and substance abuse assessment is done on each client.  The 
comprehensive mental health assessment has a bio-psychosocial evaluation which is completely 
filled out in all the charts, and information is consistent and accurate when compared to what is 
seen in the progress notes and personal care plan.   The personal care plans of five active charts 
address individual patient goals and issues addressed in progress notes.   The patient-centered 
care plan was not available for the discharged client whom PMHNP reported was seen under the 
old system that utilized different documentation of patient plans of care.  Mental health and 
substance use history and diagnoses were present in all the charts in the mental health evaluation 
and also the progress notes.  There were no screening tools in any of the charts reviewed for 
mental health or substance abuse disorders.    
All charts reviewed had a personal treatment plan with comprehensive and individualized 
goals.  Progress notes indicated an update of individualized goals and treatment plan at every 
visit.    The treatment plans addressed relapse prevention issues, mental health issues and goals 
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for medication compliance.  None of the charts had evidence of stage-wise treatment assessment 
or stage wise treatment plan.  Stage wise treatment refers to treatment strategies that are the 
client’s level of readiness to change and stage of treatment: persuasion vs. active treatment; pre-
contemplation; contemplation; action; maintenance (SAMSHA, 2007).   
All charts reviewed indicated referral source, progress notes which where extensive and 
coherent showing initial intake, comprehensive mental health assessment, progress of treatment, 
treatment updates and medication management and refill process.  Charts indicated referral to the 
aftercare program and participation in the aftercare program and individual therapy.   All active 
charts had a form that indicated coordination and collaboration with substance abuse program.    
There were no areas in the charts that indicated assessment and monitoring of interactive courses 
of mental health and substance abuse disorders.   There were no areas in the chart that indicated 
specialized interventions with substance abuse education.   Progress notes were focused on 
mental health and substance abuse relapse and education. Overall, progress notes indicated a lot 
of work on mental health, individual therapy, and some education about addiction. Several of the 
charts have documentation for coping skills, stress management and Aftercare participation.   
One of the progress notes indicated working with client to address anxiety issues, feelings of 
sadness, isolation issues, and relapse issues. Progress notes did not indicate family education as 
part of treatment interventions or specialized interventions to use peer support groups.  All six 
charts reviewed had no discharge planning.    
Analysis 
 The DDCAT toolkit was used to administer and score the DDCAT index.   Instruments, 
forms and resources were included with the toolkit for scoring.   Each element of the seven 
domains was scored using description and a scaled DDCAT ranking with the following values: 
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1-AOS related, 2-DDC related, 3-DDE related.  The toolkit offered suggestions for enhancing 
programs.  Each item included a section entitled “Item Response Coding,” which provided 
descriptions to assist in scoring the different elements and categorize them into DDCAT 
rankings. The DDCAT index also provided descriptions for scores of 2 and 4, when observations 
fell between the 1, 3, and 5 ratings. The DDCAT index had a section titled “Source” which listed 
sources of the data to be considered in determining the score.  
DDCAT Scoring Summary 
What follows in Table 4 is a table to illustrate the agency’s evaluation on each domain 
and element as outlined by the DDCAT scoring guidelines.  The seven DDCAT domains and 
each element of the seven domains are detailed below. The purpose of this scoring system is to 
determine if the agency’s services meet the guidelines for Addictions Only services (AOS), Dual 
Diagnosis Capacity (DDC) services or Dual Diagnosis Enhanced (DDE) services. 
Table 4: CAARE, Inc. Scoring Summary 
 Score Comments 
1. Program 
Structure 
  
IA. Primary focus of 
agency as stated in the 
mission statement (If 
program has mission, 
consider program 
mission) 
. 
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Primary focus is addiction, co-occurring 
disorders are treated. 
IB. Organizational 
certification and 
licensure. 
5 Is certified and/or licensed to provide both 
substance abuse and mental health 
services. 
IC. Coordination and 
collaboration with mental 
health services. 
4 Formalized coordination and collaboration, 
and the availability of case management 
staff, or staff exchange programs 
(variably used).  Meets the SAMHSA 
definition of Collaboration and has some 
informal components consistent with 
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Integration. 
ID. Financial 
incentives. 
5 Can bill for addiction or mental health 
treatments, or their combination and/or 
integration 
Sum Total =   17  
Sum total/number of 
elements(4) = SCORE  
 
4.5  
II. Program Milieu   
IIA. 
Routine expectation of 
and welcome to treatment 
for both disorders. 
3 Focus is on substance use disorders, but 
accepts mental health disorders by routine 
and if mild and relatively stable as 
reflected in program documentation 
IIB. 
Display and distribution 
of literature and patient 
educational material 
3 Routinely available for both mental health 
and substance use disorders in waiting 
areas, patient orientation materials and 
family visits, but distribution is less for 
mental health disorders. 
Sum Total  6  
Sum total/number of 
elements(2) =SCORE   
3  
III. Clinical Process: 
Assessment 
  
IIIA. 
Routine screening 
methods for mental health 
Symptoms 
3 Routine set of standard interview questions 
for mental health using a generic 
framework, e.g., ASAM-PPC 
(Dimension III) or “Biopsychosocial” 
data collection. 
IIIB. 
Routine assessment if 
screened positive for 
mental health symptoms. 
4 Assessment for mental health disorders is 
present, formal, standardized, and 
documented in 70-89% of the records. 
IIIC. 
Mental health and 
substance use diagnoses 
made and documented. 
2 Mental health diagnostic impressions or 
past treatment records are present in 
records but the program does not have a 
routine process for making and 
documenting mental health diagnoses. 
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IIID. 
Mental health and 
substance use history 
reflected in medical 
record. 
3 Routine documentation of both mental 
health and substance use disorder history in 
record in narrative section. 
IIIE. 
Program acceptance 
based on mental health 
symptom acuity: low, 
moderate, high. 
3 Admits persons in program with 
low to moderate acuity, but who are 
primarily stable. 
IIIF. 
Program acceptance 
based on severity and 
persistence of mental 
health disability: low, 
moderate, high. 
3 Admits persons in program with low to 
moderate severity and persistence 
of mental health disability. 
IIIG. 
Stage-wise assessment. 
1 Not assessed or documented 
Sum Total  19  
Sum total/number of 
elements(7)=SCORE 
2.7  
IV. Clinical Process: 
Treatment 
  
IVA. Treatment plans. 3 Plans routinely address both disorders 
although substance use disorders addressed 
as primary, mental health as secondary 
with generic interventions. 
IVB. 
Assess and monitor 
interactive courses of 
both disorders. 
2 Variable reports of progress on mental  
health disorder by individual clinicians. 
 
IVC. 
Procedures for mental 
health emergencies 
and crisis management. 
3 Documented guidelines: Referral or 
collaborations (to local mental health 
agency or emergency department). 
 
IVD. 
Stage-wise treatment. 
3 Stage of change or motivation routinely  
incorporated into individualized plan, but 
no specific stage-wise treatments 
 
IVE. 
Policies and procedures 
for medication 
3 Present, coordinated medication policies. 
Some access to prescriber for psychotropic 
medications and policies to guide 
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evaluation, management, 
monitoring, and 
compliance 
prescribing are provided.  Monitoring of 
the medication is largely provided by 
the prescriber 
IVF. 
Specialized interventions 
with mental health 
content. 
3 In program format as generalized 
intervention (e.g., stress management) 
with penetration into routine services. 
Routine clinician adaptation 
of an evidence-based addiction 
treatment (e.g., MI, CBT, Twelve-Step 
Facilitation) 
IVG. 
Education about mental 
health disorders, 
treatment, and interaction 
with substance use 
disorders. 
 
4 Specific content for specific co-
morbidities; variably offered in individual 
and/or group formats. 
IVH. 
Family education and 
support 
3 Mental health disorders routinely, but 
informally incorporated into family 
education or support sessions. Available as 
needed. 
IVI. 
Specialized interventions 
to facilitate use of peer 
support groups in 
planning or during 
Treatment 
3 Generic format on site, but no specific 
or intentional facilitation based on mental 
health disorders. More routine facilitation 
to addiction peer support groups (e.g., AA, 
NA). 
IVJ. 
Availability of peer 
recovery supports for 
patients with co-occurring 
disorders. 
3 Off site and facilitated with contact persons 
or informal matching with peer supports 
in the community, some co-occurring 
focus 
Sum Total  30  
Sum total/number of 
elements(10)=SCORE 
3  
V. Continuity of Care   
VA. 
Co-occurring disorders 
addressed in discharge 
2 Variably addressed by individual clinicians 
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planning process. 
VB. 
Capacity to maintain 
treatment continuity. 
2 No formal protocol to manage mental 
health needs once program is completed, 
but some individual clinicians may provide 
extended care until appropriate linkage 
takes place. Variable documentation 
VC. 
Focus on ongoing 
recovery issues for 
both disorders. 
2 Individual clinician determined 
VD. 
Specialized interventions 
to facilitate use of 
community-based peer 
support groups during 
discharge planning. 
3 Generic, but no specific or intentional 
facilitation based on mental health 
disorders. More routine facilitation 
to addiction peer support groups 
(e.g., AA, NA) upon discharge 
VE. 
Sufficient supply and 
compliance plan for 
medications is 
documented. 
2 Variable or undocumented availability of 
30-day or supply to next appointment off-
site 
Sum Total  12  
Sum total/number of 
elements(5)=SCORE 
 
2.4  
VI. Staffing   
VIA. 
Psychiatrist or other 
physician or prescriber of 
psychotropic medications. 
5 Staff member, present on site for clinical, 
supervision, treatment team, and/or 
administration 
VIB. 
On-site clinical staff 
members with mental 
health licensure (doctoral 
or masters level), or 
competency or 
substantive experience. 
3 25-33% of clinical staff have either a 
license in a mental health profession 
or substantial experience sufficient 
to establish competence in mental health 
treatment 
VIC . 
Access to mental health 
clinical supervision or 
consultation. 
4 Routinely provided on site by staff 
member. 
51 
 
VID. 
Case review, staffing or 
utilization review 
procedures emphasize 
and support co-occurring 
disorder treatment. 
1 Not conducted 
VIE. 
Peer/Alumni supports are 
available with co-ccurring 
disorders. 
4 Available on site, with co-occurring 
disorders, either as paid staff, volunteers, 
or program alumni. Variable referrals made 
Sum Total 17  
Sum total/number of 
elements(5)=SCORE 
3.4  
VII. Training   
VIIA. 
All staff members have 
basic training in attitude 
towards consumers, dual 
diagnosis prevalence, 
common signs and 
symptoms, 
detection and triage for 
co-occurring disorders. 
2 Variably trained, no systematic agency 
training plan or individual staff member 
training (1-24% of clinical staff trained)  
 
VIIB. 
Clinical staff members 
have advanced 
specialized training in 
integrated psychosocial or 
pharmacological 
treatment of persons with 
co-occurring disorders. 
2 Variably trained, no systematic agency 
training plan or individual staff member 
training (1-24% of clinical staff trained)  
 
Sum Total  4  
Sum total/number of 
elements(2)=SCORE 
2  
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DDCAT Index Program Category: 
Scale Method 
OVERALL SCORE  21 
(Sum of Scale Scores/number of domains (7) = 3 
Table 5: CAARE’s DDC Capability in each category.  
DUAL DIAGNOSIS CAPABILITY: 
AOS (1 - 1.99)  None 
AOS/DDC (2 - 2.99) Training (2), Clinical Assessment (2.7), Continuity of Care (2.7) 
DDC (3 - 3.49)  Program milieu (3), Clinical Process/Treatment (3), Staffing (3.4) 
DDC/DDE (3.5 - 4.49) None 
DDE (4.5 - 5.0) Program Structure (4.5) 
 
DDCAT Index Program Category: 3 
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CHAPTER 10: DISCUSSION OF FINDINGS 
 The elements in each domain that scored below 3 were categorized as meeting the highest 
priority to reach DDC level.  This means that the agency is not performing at the “capacity” level 
and recommendations will be made to reach the DDC status. Elements in each domain that 
scored above 3 were categorized as meeting the lowest priority to reach DDC level.  This means 
that the agency is already performing at the “capacity” level and no recommendations are needed 
to reach DDC status.  Similarly, the domains that scored below 3 were categorized as having the 
highest priority to reach DDC level, while the domains that scored 3 or greater were categorized 
as meeting the lowest priority to reach DDC level.  
Program Structure 
Program structure scored a sum total of 17 and a DDCAT index score of 4.5.   The DDCAT 
index score of 4.5 indicates that program structure is DDC and can achieve DDE.  There were no 
elements in program structure with the highest priority to reach DDC level.  All elements scored 
above a 3 with some elements scoring at a DDE level.   Organizational certification and financial 
incentives being the lowest priority to meet dual diagnosis capability; both elements scored 5.  
Elements of primary focus of agency as stated in the mission statement and coordination and 
collaboration with mental health services had the highest priority to meet dual diagnosis 
enhanced care scoring 4 and 3.    
Program Milieu 
Program Milieu had a sum total of 6 with a DDCAT index score of 3.  The DDCAT index score 
of 3 indicates that program milieu is DDC and can achieve DDE. There were no elements in 
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program milieu with the highest priority to reach DDC level.  Both elements: routine expectation 
of and welcome to treatment for both disorders scored 3 indicating DDC levels.    
Clinical Process: Assessment 
 Clinical Process: Assessment had a sum total of 19 and a DDCAT index score of 2.7 
indicating AOS/DDC.  Elements in program milieu of highest priority to achieve DDC were 
mental health and substance use diagnoses made and documented, and stage wise assessment 
completed.   All other elements were at DDC or DDE levels.    
Clinical Process: Treatment 
 Clinical Process: Treatment had a sum total of 30 with a DDCAT index score of 3 
indicating DDC.  Elements with highest priority to achieve DDC was assessing and monitoring 
interactive courses of both disorders.  All other elements scored at DDC or DDE levels.   
Continuity of Care 
 Continuity of Care had a sum total of 12 with a DDCAT index score of 2.4 indicating 
AOS/DDC level.   Elements in continuity of care of highest priority to achieve DDC were co-
occurring disorders addressed in discharge planning process, capacity to maintain treatment 
continuity, focus on ongoing recovery issues for both disorders; sufficient supply and 
compliance plan for medications is documented.   All other elements were DDC.   
Staffing 
Staffing had a sum total of 17 and a DDCAT index score of 3.4 indicating DDC level.  Elements 
of highest priority to achieve DDC in staffing was case review, staffing or utilization review 
procedures emphasize and support co-occurring disorder treatment.  All other elements in 
staffing were DDC or DDE.    
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Training 
 Training had a sum total of 4 with a DDCAT index score of 2 indicating AOS/DDC 
level.  All elements in training have highest priority to achieve DDC: all staff members have 
basic training in attitudes, prevalence, common signs and symptoms, detection and triage for co-
occurring disorders, and clinical staff members have specialized training in integrated 
psychosocial or pharmacological treatment of persons with co-occurring disorders.   
 Overall the program evaluation revealed that the agency’s DDCAT Index Program 
Category is dual diagnosis capable given the overall score of 3.  Programs that score between 3-
3.49 are dual diagnosis capable.    
 Each of the domains assessed scored differently indicating DDC or DDE.  There was no 
domain that scored at the AOS level.  Overall the DDCAT domains that required the most 
improvement for endorsement for dual diagnosis capability were clinical process: assessments, 
training and continuity of care, while program structure had the lowest priority for dual diagnosis 
capability.  The program scored 3 on 80% of the elements on the toolkit.    
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Table 6: Areas that can be targeted by CAARE, Inc. for enhancement (DDC) and 
recommendations for attaining enhance services. 
Areas for Enhancement Recommendations 
Clinical: Assessment 
IIIG. Assess patients’ stage of change for both 
their substance use and mental health 
problems.  
 
 
Clinicians may use well established measures 
such as the URICA, Socrates measures to 
assess patients’ stage of change, or treatment 
motivation.  A patient’s global rating scale of 
pre-contemplation, contemplation, preparation, 
action and maintenance should be included in 
the medical record. The agency was provided 
the URICA and Socrates measures 
standardized forms with instructions on how to 
use the forms.   
Treatment 
IVB.  Observe and document changes in 
mental health and substance use symptoms 
over time. 
Clinicians or patient use of time line follow-
back (TLFB) calendars to observe and 
document changes in mental health and 
substance use symptoms. The agency was 
provided the time line follow-back (TLFB) 
calendars with instructions on how to use the 
forms.  
Continuity of Care 
VA. 
Implement discharge procedures that plan for 
Develop admission and discharge criteria and 
set up referral procedure.  Agency provided 
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mental health and substance use services. 
VB. 
Assertively link patients to peer support groups  
welcoming to COD upon discharge 
VC. 
Focus on ongoing recovery from both 
disorders. 
with SAMHSA’s Illness Management and 
Recovery strategy EBP-kit to create agency 
admission and discharge criteria and set up 
referral procedure. 
Staffing 
VID 
Case review, staffing or 
utilization review procedures emphasize 
and support co-occurring 
disorder treatment. 
Implement routine case reviews that support 
co-occurring disorder treatment. 
Training 
VII 
Implement training plan that routinely includes 
basic training on co-occurring disorders 
 
Develop minimum core competencies for each 
clinician, in accordance with job role, level of 
training or license to provide properly matched 
integrated service to individuals in their 
system.  The agency was provided the core 
clinical competency training required for each 
clinician in accordance to their specified job.  
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CHAPTER 11: OUTCOMES/END PRODUCTS/DELIVERABLES 
       At the end of the site visit, the agency director and staff members received preliminary 
verbal feedback.  Following the formal analysis of results, the agency received final feedback in 
two formats: (1) an oral presentation to discuss the findings, recommendations, and agency 
response, and (2) a written report.  The written report included a communication of appreciation, 
a review of what programs and sources of data were assessed, a summary of the agencies scores, 
including their categorical rating of AOS, DDC, or DDE ( See Table 5), an acknowledgment of 
relative strengths in existing services, and recommendations of potential areas that can be 
targeted for enhancement (See Table 6). 
Agency Response to Recommendations  
       The agency director and staff members received the results of the evaluation positively.  
They were excited that the agency substance abuse and mental health programs received an 
overall score at the dual diagnosis capable level.  The agency director and staff engaged in a 
constructive dialogue as the report was presented and discussed preliminary strategies for 
following the recommendations to enhance the elements that had not scored in the dual diagnosis 
capable level.   They stated that they were willing to develop policy and system changes to 
formally implement these recommendations. 
Summary 
Overall the DDCAT score for the agency was 3 and over 80% of the domains evaluated scored 
in the dual diagnosis capable category.   The domains that met higher priority to meet dual 
diagnosis capability had seven elements that needed meaningful improvements.  The agency 
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could enhance the quality of its services in a relatively short amount of time by implementing the 
outlined recommendations given that there were only seven elements out of thirty five elements 
that needed enhancement.   The agency reported their intent to achieve DDE category, they 
would benefit from further training and technical assistance to help them achieve DDE category.    
Conclusion 
 The program evaluation revealed that the DDCAT index is a valuable tool to evaluate the 
relative strengths and challenges of a community based agency regarding capability to provide 
integrative services for dual diagnosed patients.  In addition, the DDCAT index can be used to 
guide efforts to improve services in community based agencies that treat dual diagnosed 
individuals, thus enhancing their ability to facilitate better treatment outcomes.    
 In the beginning of the evaluation, the agency was not aware what category of service 
they provided.  The results of the evaluation will enable the agency to report in their mission 
statement that the agency is DDC, which should help generate more funding.   The continual use 
of the DDCAT index will enable administrators and providers enhance the quality of care and 
efficiency of their agencies to serve the dual diagnosed.   
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